ImmunoGen Inc. (IMGN)
NASDAQ: IMGN
· Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM
ImmunoGen Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -73.52M | -182.03M | -239.8M | -222.93M | -201.09M | -160.68M | -129.4M | -139.3M | -70.74M | -55.78M | -49.34M |
Depreciation & Amortization | 1.73M | 1.73M | 1.76M | 1.78M | 1.82M | 1.85M | 1.94M | 2.02M | 2.09M | 2.15M | 2.12M |
Stock-Based Compensation | 33.05M | 30.73M | 28.27M | 25.61M | 21.3M | 19.29M | 18.06M | 17.48M | 14.91M | 15.31M | 15.02M |
Other Working Capital | -25.12M | -12.21M | -16.5M | -28.01M | -35.37M | -44.05M | -37.54M | -17.19M | -23.87M | -18.14M | -19.88M |
Other Non-Cash Items | -34.34M | -8.51M | -8.86M | -8.67M | -7.8M | -5.79M | -16.27M | -26.05M | -41.77M | -53.65M | -49.03M |
Deferred Income Tax | 61.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18K |
Change in Working Capital | -186.2M | -106.79M | -43.49M | -25.6M | -29.69M | -40.98M | -40.53M | -23.55M | -19.49M | -18.64M | -13.73M |
Operating Cash Flow | -197.89M | -264.87M | -262.12M | -229.8M | -215.48M | -186.31M | -166.2M | -169.42M | -115.01M | -110.61M | -94.93M |
Capital Expenditures | -1.89M | -1.14M | -1.27M | -1.36M | -1.49M | -1.01M | -848K | -1.43M | -1.17M | -1.81M | -1.79M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.89M | -1.14M | -1.27M | -1.36M | -1.49M | -1.01M | -848K | -1.43M | -1.17M | -1.81M | -1.79M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 495.8M | 464.12M | 26.97M | 27.55M | 280.71M | 321.65M | 321.59M | 355.74M | 173.72M | 132.46M | 132.54M |
Financial Cash Flow | 495.8M | 464.12M | 26.97M | 27.55M | 280.71M | 321.65M | 321.59M | 355.74M | 173.72M | 132.46M | 132.54M |
Net Cash Flow | 296.02M | 198.11M | -236.41M | -203.61M | 63.75M | 134.34M | 154.54M | 184.89M | 57.54M | 20.03M | 35.82M |
Free Cash Flow | -199.78M | -266.01M | -263.38M | -231.17M | -216.96M | -187.32M | -167.04M | -170.85M | -116.17M | -112.42M | -96.72M |